Nathaniel Weygant

Nathaniel Weygant

Fujian University of Traditional Chinese Medicine - Fuzhou / China
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4650907
福建中医药大学
person_outline Nathaniel Weygant's MOST POPULAR ARTICLES
1-) DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancerSM Sureban, R May, D Qu, N Weygant, P Chandrakesan, N Ali, ...PloS one 8 (9), e73940, 20131412013
2-) Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1N Weygant, D Qu, WL Berry, R May, P Chandrakesan, DB Owen, ...Molecular cancer 13 (1), 1-14, 20141202014
3-) XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanismSM Sureban, R May, N Weygant, D Qu, P Chandrakesan, ...Cancer letters 351 (1), 151-161, 20141202014
4-) Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cellsP Chandrakesan, J Yao, D Qu, R May, N Weygant, Y Ge, N Ali, ...Molecular Cancer 16, 1-14, 20171152017
5-) DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinomaN Weygant, D Qu, R May, RM Tierney, WL Berry, L Zhao, S Agarwal, ...Oncotarget 6 (4), 2193, 2014992014